Search results
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Bowel cancer patient first in England to have personalised jab to fight disease
Press Association News via AOL· 4 days agoI hope this will help other people.” The vaccine was created using mRNA technology and is being...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 3 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 4 days agoThe current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still offering solid...
New approach uses 'cloaked' proteins to deliver cancer-killing therapeutics into cells
Phys.org· 7 days agoThe generalizable technique could lead to repurposing thousands of commercial protein products, including antibodies, for biological research and therapeutic applications. The group's paper, ...
Southampton: 'Ground-breaking' cancer vaccine trial announced
BBC News· 4 days agoThousands of patients will be able to access "ground-breaking" cancer vaccines, as part of an NHS...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 5 days agoModerna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine,...
'Cloaked' proteins deliver cancer-killing therapeutics into cells
Science Daily· 7 days agoThe "cloaked" proteins can be captured by lipid nanoparticles, which are akin to tiny bubbles of fat. The lead author is doctoral student Azmain Alamgir, who works in the labs of the paper's ...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology...
Benzinga· 7 days agoPlanegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid
New U.S. bird-flu case is first with respiratory symptoms, CDC says
Morningstar· 4 days agoA new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve acute respiratory symptoms, the Centers for Disease Control and Prevention said Thursday.